Short-course radiation for high-risk breast cancer
Part of Cancer, Skin clinical trials.
This trial tests a short, more intense radiation schedule for women with certain breast cancer types or who are under 40. It aims to reduce treatment time while still targeting the whole breast and any high-risk areas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have breast cancer confirmed by biopsy.
- You are under 40, or between 40–70 with a less common type (lobular, HER2-positive, or triple-negative).
- You had breast-conserving surgery (lumpectomy) with clean margins at least 0.2 cm.
- No past radiation therapy to the chest area.
- No known BRCA1/2 mutation (if tested).
- No other serious medical or autoimmune conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving a single, very targeted dose of radiation right after surgery for early-stage breast cancer. It is for women age 40+ with small, low-risk tumors (Luminal A or B) that have been fully removed and have not spread to lymph nodes.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This study tests a shorter course of radiation therapy after breast reconstruction surgery for people with breast cancer. It aims to see if fewer, larger doses of radiation are safe and effective after mastectomy with reconstruction.
This trial tests a shorter, more targeted course of daily radiation for early-stage breast cancer. The radiation plan is adjusted each day to better fit your body, which may reduce side effects.
This trial compares a 5-day course of whole breast radiation plus a boost to the standard 9-day course for people with early-stage breast cancer who have certain risk factors, such as high-grade tumors or younger age. The goal is to see if the shorter treatment is just as safe and effective.
This study tests giving a shorter course of radiation to the whole breast after chemotherapy for early breast cancer. It aims to make treatment more convenient and may be an option for people who have had breast-conserving surgery.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.